PNC-28 is a synthetic peptide derived from a mitochondrial targeting sequence of p53. It is designed for research investigating selective apoptotic mechanisms in malignant cell populations and is used as a tool in studies related to cancer biology and targeted peptide interactions.

PNC-28 is utilized in laboratory research settings focused on mitochondrial membrane interactions, apoptotic signaling, and cellular stress response pathways. It is commonly applied in experimental models comparing malignant and non-malignant cell behavior.

PNC-28 supports research into apoptosis regulation, p53-associated signaling, differential cytotoxicity in transformed cells, and tumor suppression mechanisms. It is also explored in studies examining oncogenic processes and cellular homeostasis in vitro.

PNC-28 is suitable for researchers and institutions conducting advanced studies in oncology, apoptosis regulation, cancer peptide research, and experimental models focused on malignant cell targeting.